Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis
Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an adjunct to medical therapy, with the intent of reducing bacterial burden and improving cure rates. We conducted an individual patient data meta...
Uložené v:
| Vydané v: | Clinical infectious diseases Ročník 62; číslo 7; s. 887 - 895 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.04.2016
|
| Predmet: | |
| ISSN: | 1537-6591 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an adjunct to medical therapy, with the intent of reducing bacterial burden and improving cure rates. We conducted an individual patient data metaanalysis to evaluate the effectiveness of surgery as adjunctive therapy for MDR-tuberculosis.
Individual patient data, was obtained from the authors of 26 cohort studies, identified from 3 systematic reviews of MDR-tuberculosis treatment. Data included the clinical characteristics and medical and surgical therapy of each patient. Primary analyses compared treatment success (cure and completion) to a combined outcome of failure, relapse, or death. The effects of all forms of resection surgery, pneumonectomy, and partial lung resection were evaluated.
A total of 4238 patients from 18 surgical studies and 2193 patients from 8 nonsurgical studies were included. Pulmonary resection surgery was performed on 478 patients. Partial lung resection surgery was associated with improved treatment success (adjusted odds ratio [aOR], 3.0; 95% confidence interval [CI], 1.5-5.9; I(2)R, 11.8%), but pneumonectomy was not (aOR, 1.1; 95% CI, .6-2.3; I(2)R, 13.2%). Treatment success was more likely when surgery was performed after culture conversion than before conversion (aOR, 2.6; 95% CI, 0.9-7.1; I(2)R, 0.2%).
Partial lung resection, but not pneumonectomy, was associated with improved treatment success among patients with MDR-tuberculosis. Although improved outcomes may reflect patient selection, partial lung resection surgery after culture conversion may improve treatment outcomes in patients who receive optimal medical therapy. |
|---|---|
| AbstractList | Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an adjunct to medical therapy, with the intent of reducing bacterial burden and improving cure rates. We conducted an individual patient data metaanalysis to evaluate the effectiveness of surgery as adjunctive therapy for MDR-tuberculosis.
Individual patient data, was obtained from the authors of 26 cohort studies, identified from 3 systematic reviews of MDR-tuberculosis treatment. Data included the clinical characteristics and medical and surgical therapy of each patient. Primary analyses compared treatment success (cure and completion) to a combined outcome of failure, relapse, or death. The effects of all forms of resection surgery, pneumonectomy, and partial lung resection were evaluated.
A total of 4238 patients from 18 surgical studies and 2193 patients from 8 nonsurgical studies were included. Pulmonary resection surgery was performed on 478 patients. Partial lung resection surgery was associated with improved treatment success (adjusted odds ratio [aOR], 3.0; 95% confidence interval [CI], 1.5-5.9; I(2)R, 11.8%), but pneumonectomy was not (aOR, 1.1; 95% CI, .6-2.3; I(2)R, 13.2%). Treatment success was more likely when surgery was performed after culture conversion than before conversion (aOR, 2.6; 95% CI, 0.9-7.1; I(2)R, 0.2%).
Partial lung resection, but not pneumonectomy, was associated with improved treatment success among patients with MDR-tuberculosis. Although improved outcomes may reflect patient selection, partial lung resection surgery after culture conversion may improve treatment outcomes in patients who receive optimal medical therapy. BACKGROUNDMedical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an adjunct to medical therapy, with the intent of reducing bacterial burden and improving cure rates. We conducted an individual patient data metaanalysis to evaluate the effectiveness of surgery as adjunctive therapy for MDR-tuberculosis.METHODSIndividual patient data, was obtained from the authors of 26 cohort studies, identified from 3 systematic reviews of MDR-tuberculosis treatment. Data included the clinical characteristics and medical and surgical therapy of each patient. Primary analyses compared treatment success (cure and completion) to a combined outcome of failure, relapse, or death. The effects of all forms of resection surgery, pneumonectomy, and partial lung resection were evaluated.RESULTSA total of 4238 patients from 18 surgical studies and 2193 patients from 8 nonsurgical studies were included. Pulmonary resection surgery was performed on 478 patients. Partial lung resection surgery was associated with improved treatment success (adjusted odds ratio [aOR], 3.0; 95% confidence interval [CI], 1.5-5.9; I(2)R, 11.8%), but pneumonectomy was not (aOR, 1.1; 95% CI, .6-2.3; I(2)R, 13.2%). Treatment success was more likely when surgery was performed after culture conversion than before conversion (aOR, 2.6; 95% CI, 0.9-7.1; I(2)R, 0.2%).CONCLUSIONSPartial lung resection, but not pneumonectomy, was associated with improved treatment success among patients with MDR-tuberculosis. Although improved outcomes may reflect patient selection, partial lung resection surgery after culture conversion may improve treatment outcomes in patients who receive optimal medical therapy. |
| Author | Garcia-Garcia, L Quelapio, M I D Ponce-de-Leon, A Shim, Tae Sun Granich, R M Hopewell, P Schaaf, H S Flanagan, K Lancaster, J Royce, S Shean, K D'Ambrosio, L Benedetti, Andrea Strand, M J Viiklepp, Piret Cobelens, F Menzies, D van der Walt, M Quy, H T Koh, Won-Jung Vargas, M H van der Werf, T S Hollm-Delgado, M G Tabarsi, P Burgos, M Ahuja, S Narita, M Holtz, T H Tupasi, T E Enarson, D Falzon, D Fox, Gregory J DeRiemer, K Salim, M Yim, Jae-Joon Leimane, V Westenhouse, J Centis, R Pérez-Guzmán, C Avendaño, M Palmero, D Mitnick, Carole D Sung, S W Chan, Edward D Cox, H Gandhi, N Sifuentes-Osornio, J Menzies, Dick O'Riordan, P Yew, W W Li, J Pena, J Chiang, Chen-Yuan de Lange, W C M Park, S K Riekstina, V Becerra, Mercedes Keshavjee, Salmaan Iseman, M Robert, Jerome Kim, H R Shah, L Odendaal, R Shiraishi, Yuji Nathanson, E Banerjee, R Shin, Sonya S Flood, J Migliori, G B Jarlsberg, L G Seung, K J Bauer, M Pai, M Pasvol, Geoffrey Ashkin, D Lange, C Sotgiu, G Leung, C C van Altena, R |
| Author_xml | – sequence: 1 givenname: Gregory J surname: Fox fullname: Fox, Gregory J organization: Montreal Chest Institute, McGill University, Canada – sequence: 2 givenname: Carole D surname: Mitnick fullname: Mitnick, Carole D organization: Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts – sequence: 3 givenname: Andrea surname: Benedetti fullname: Benedetti, Andrea organization: Montreal Chest Institute, McGill University, Canada – sequence: 4 givenname: Edward D surname: Chan fullname: Chan, Edward D organization: Departments of Medicine and Academic Affairs, Denver Veterans Affairs Medical Center, Colorado – sequence: 5 givenname: Mercedes surname: Becerra fullname: Becerra, Mercedes organization: Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts – sequence: 6 givenname: Chen-Yuan surname: Chiang fullname: Chiang, Chen-Yuan organization: Wan Fang Hospital, Taipei Medical University, Taiwan – sequence: 7 givenname: Salmaan surname: Keshavjee fullname: Keshavjee, Salmaan organization: Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts – sequence: 8 givenname: Won-Jung surname: Koh fullname: Koh, Won-Jung organization: Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 9 givenname: Yuji surname: Shiraishi fullname: Shiraishi, Yuji organization: Section of Chest Surgery, Fukujuji Hospital, Tokyo, Japan – sequence: 10 givenname: Piret surname: Viiklepp fullname: Viiklepp, Piret organization: Estonian Tuberculosis Registry, National Institute for Health Development, Tallinn – sequence: 11 givenname: Jae-Joon surname: Yim fullname: Yim, Jae-Joon organization: Department of Internal Medicine, Seoul National University College of Medicine, South Korea – sequence: 12 givenname: Geoffrey surname: Pasvol fullname: Pasvol, Geoffrey organization: Department of Infection & Tropical Medicine, Imperial College London, United Kingdom – sequence: 13 givenname: Jerome surname: Robert fullname: Robert, Jerome organization: Laboratoire de Bacteriologie-Hygiene, University Pierre and Marie Curie, Paris, France – sequence: 14 givenname: Tae Sun surname: Shim fullname: Shim, Tae Sun organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea – sequence: 15 givenname: Sonya S surname: Shin fullname: Shin, Sonya S organization: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts – sequence: 16 givenname: Dick surname: Menzies fullname: Menzies, Dick organization: Montreal Chest Institute, McGill University, Canada – sequence: 17 givenname: S surname: Ahuja fullname: Ahuja, S – sequence: 18 givenname: D surname: Ashkin fullname: Ashkin, D – sequence: 19 givenname: M surname: Avendaño fullname: Avendaño, M – sequence: 20 givenname: R surname: Banerjee fullname: Banerjee, R – sequence: 21 givenname: M surname: Bauer fullname: Bauer, M – sequence: 22 givenname: M surname: Burgos fullname: Burgos, M – sequence: 23 givenname: R surname: Centis fullname: Centis, R – sequence: 24 givenname: F surname: Cobelens fullname: Cobelens, F – sequence: 25 givenname: H surname: Cox fullname: Cox, H – sequence: 26 givenname: L surname: D'Ambrosio fullname: D'Ambrosio, L – sequence: 27 givenname: W C M surname: de Lange fullname: de Lange, W C M – sequence: 28 givenname: K surname: DeRiemer fullname: DeRiemer, K – sequence: 29 givenname: D surname: Enarson fullname: Enarson, D – sequence: 30 givenname: D surname: Falzon fullname: Falzon, D – sequence: 31 givenname: K surname: Flanagan fullname: Flanagan, K – sequence: 32 givenname: J surname: Flood fullname: Flood, J – sequence: 33 givenname: N surname: Gandhi fullname: Gandhi, N – sequence: 34 givenname: L surname: Garcia-Garcia fullname: Garcia-Garcia, L – sequence: 35 givenname: R M surname: Granich fullname: Granich, R M – sequence: 36 givenname: M G surname: Hollm-Delgado fullname: Hollm-Delgado, M G – sequence: 37 givenname: T H surname: Holtz fullname: Holtz, T H – sequence: 38 givenname: P surname: Hopewell fullname: Hopewell, P – sequence: 39 givenname: M surname: Iseman fullname: Iseman, M – sequence: 40 givenname: L G surname: Jarlsberg fullname: Jarlsberg, L G – sequence: 41 givenname: H R surname: Kim fullname: Kim, H R – sequence: 42 givenname: J surname: Lancaster fullname: Lancaster, J – sequence: 43 givenname: C surname: Lange fullname: Lange, C – sequence: 44 givenname: V surname: Leimane fullname: Leimane, V – sequence: 45 givenname: C C surname: Leung fullname: Leung, C C – sequence: 46 givenname: J surname: Li fullname: Li, J – sequence: 47 givenname: D surname: Menzies fullname: Menzies, D – sequence: 48 givenname: G B surname: Migliori fullname: Migliori, G B – sequence: 49 givenname: M surname: Narita fullname: Narita, M – sequence: 50 givenname: E surname: Nathanson fullname: Nathanson, E – sequence: 51 givenname: R surname: Odendaal fullname: Odendaal, R – sequence: 52 givenname: P surname: O'Riordan fullname: O'Riordan, P – sequence: 53 givenname: M surname: Pai fullname: Pai, M – sequence: 54 givenname: D surname: Palmero fullname: Palmero, D – sequence: 55 givenname: S K surname: Park fullname: Park, S K – sequence: 56 givenname: J surname: Pena fullname: Pena, J – sequence: 57 givenname: C surname: Pérez-Guzmán fullname: Pérez-Guzmán, C – sequence: 58 givenname: A surname: Ponce-de-Leon fullname: Ponce-de-Leon, A – sequence: 59 givenname: M I D surname: Quelapio fullname: Quelapio, M I D – sequence: 60 givenname: H T surname: Quy fullname: Quy, H T – sequence: 61 givenname: V surname: Riekstina fullname: Riekstina, V – sequence: 62 givenname: S surname: Royce fullname: Royce, S – sequence: 63 givenname: M surname: Salim fullname: Salim, M – sequence: 64 givenname: H S surname: Schaaf fullname: Schaaf, H S – sequence: 65 givenname: K J surname: Seung fullname: Seung, K J – sequence: 66 givenname: L surname: Shah fullname: Shah, L – sequence: 67 givenname: K surname: Shean fullname: Shean, K – sequence: 68 givenname: J surname: Sifuentes-Osornio fullname: Sifuentes-Osornio, J – sequence: 69 givenname: G surname: Sotgiu fullname: Sotgiu, G – sequence: 70 givenname: M J surname: Strand fullname: Strand, M J – sequence: 71 givenname: S W surname: Sung fullname: Sung, S W – sequence: 72 givenname: P surname: Tabarsi fullname: Tabarsi, P – sequence: 73 givenname: T E surname: Tupasi fullname: Tupasi, T E – sequence: 74 givenname: M H surname: Vargas fullname: Vargas, M H – sequence: 75 givenname: R surname: van Altena fullname: van Altena, R – sequence: 76 givenname: M surname: van der Walt fullname: van der Walt, M – sequence: 77 givenname: T S surname: van der Werf fullname: van der Werf, T S – sequence: 78 givenname: J surname: Westenhouse fullname: Westenhouse, J – sequence: 79 givenname: W W surname: Yew fullname: Yew, W W |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26757804$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kMtOwzAQRS0Eog_Y8AHISzYBO3Fih11VXpVagaCso0lsV64Sp_hR1L8niLIYjXR07mh0J-jU9lYhdEXJLSVldtcYOcw3IekJGtM840mRl3SEJt5vCaFUkPwcjdKC51wQNka7j-g2yh0weAwWz-Q22iaYvcJrpyB0ygase4dXsQ1GurhJ3pU3PsDA17FWroltP4B7PLN4YaXZGxmhxW8QzG_2AQLglQoAFtrDIF6gMw2tV5fHPUWfT4_r-UuyfH1ezGfLpMkpCUmZMq2YpEBzMfxcSM14TutcNEoILRqqmZDZoDJelyojNYWGa6a1LBjhUKdTdPN3d-f6r6h8qDrjG9W2YFUffUU5T0XGOOODen1UY90pWe2c6cAdqv-W0h8wC2qh |
| CitedBy_id | crossref_primary_10_1016_S0140_6736_18_31644_1 crossref_primary_10_1111_resp_13304 crossref_primary_10_1186_s12879_016_1585_0 crossref_primary_10_1016_j_thorsurg_2022_04_009 crossref_primary_10_25005_2074_0581_2025_27_2_362_372 crossref_primary_10_3201_eid2603_190997 crossref_primary_10_1038_s41572_024_00504_2 crossref_primary_10_1183_13993003_01799_2016 crossref_primary_10_1080_24745332_2023_2226006 crossref_primary_10_54921_2413_0346_2025_13_1_39_45 crossref_primary_10_1016_j_clinsp_2023_100169 crossref_primary_10_1016_j_cmi_2016_10_008 crossref_primary_10_1186_s12879_022_07836_y crossref_primary_10_1016_j_chest_2022_09_037 crossref_primary_10_1128_microbiolspec_TNMI7_0042_2017 crossref_primary_10_1513_AnnalsATS_202004_318CME crossref_primary_10_1016_j_jiph_2025_102920 crossref_primary_10_1016_j_rmcr_2019_100829 crossref_primary_10_1016_j_coph_2021_05_007 crossref_primary_10_1093_cid_cix274 crossref_primary_10_1016_j_ijid_2019_02_039 crossref_primary_10_1038_nrdp_2016_76 crossref_primary_10_1016_j_mmifmc_2022_02_001 crossref_primary_10_1016_S0140_6736_19_31882_3 crossref_primary_10_1093_ejcts_ezab337 crossref_primary_10_3390_tropicalmed8080393 crossref_primary_10_1016_j_ijid_2020_02_030 crossref_primary_10_1164_rccm_201909_1874ST crossref_primary_10_1183_20734735_027218 crossref_primary_10_1016_j_ccm_2019_08_002 crossref_primary_10_1016_j_ijid_2020_02_039 crossref_primary_10_1080_24745332_2022_2039499 crossref_primary_10_1183_13993003_02308_2016 crossref_primary_10_3389_fimmu_2020_612564 crossref_primary_10_1111_hiv_12748 crossref_primary_10_1186_s12879_018_3442_9 crossref_primary_10_1186_s12883_017_0996_x crossref_primary_10_1186_s13741_025_00530_y crossref_primary_10_1016_j_jmii_2023_07_006 crossref_primary_10_3390_app10082734 crossref_primary_10_1016_j_micpath_2025_107794 crossref_primary_10_1016_j_ijsu_2022_106790 crossref_primary_10_1016_j_rmcr_2021_101506 crossref_primary_10_1080_17476348_2024_2418932 |
| ContentType | Journal Article |
| Copyright | The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. |
| Copyright_xml | – notice: The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. |
| CorporateAuthor | Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB |
| CorporateAuthor_xml | – name: Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB |
| DBID | CGR CUY CVF ECM EIF NPM 7U8 7X8 C1K JXQ |
| DOI | 10.1093/cid/ciw002 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed TOXLINE MEDLINE - Academic Environmental Sciences and Pollution Management Toxline |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) TOXLINE MEDLINE - Academic Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE TOXLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1537-6591 |
| EndPage | 895 |
| ExternalDocumentID | 26757804 |
| Genre | Research Support, Non-U.S. Gov't Meta-Analysis Journal Article |
| GroupedDBID | --- ..I .2P .I3 .ZR 08P 0R~ 1KJ 1TH 29B 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 70D AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPLY ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACHIC ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFZL AFIYH AFOFC AFRAH AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN AQKUS AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CGR CS3 CUY CVF CZ4 DAKXR DCCCD DIK DILTD DOOOF DU5 D~K E3Z EBS ECM EE~ EIF EJD EMOBN ENERS ESX F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HW0 HZ~ IOX IPSME J21 JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KAQDR KBUDW KOP KSI KSN L7B M49 MHKGH MJL ML0 N9A NGC NOMLY NOYVH NPM NU- NVLIB O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 W8F X7H YAYTL YKOAZ YXANX ~91 ~S- 7U8 7X8 ABPQP ADNBA ADQXQ AEMQT AJBYB AJNCP ALXQX C1K JXQ JXSIZ |
| ID | FETCH-LOGICAL-c510t-924fe4d1a1588056df4751b58ce88f8c1f48d351047b9e30b1ac7f4ffd6407ab2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 59 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000374248700011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| IngestDate | Sun Nov 09 10:02:50 EST 2025 Wed Feb 19 01:57:27 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | metaanalysis multidrug resistant tuberculosis pneumonectomy individual patient data thoracic surgery |
| Language | English |
| License | The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c510t-924fe4d1a1588056df4751b58ce88f8c1f48d351047b9e30b1ac7f4ffd6407ab2 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://academic.oup.com/cid/article-pdf/62/7/887/16788682/ciw002.pdf |
| PMID | 26757804 |
| PQID | 1772834747 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_1772834747 pubmed_primary_26757804 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-04-01 |
| PublicationDateYYYYMMDD | 2016-04-01 |
| PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Clinical infectious diseases |
| PublicationTitleAlternate | Clin Infect Dis |
| PublicationYear | 2016 |
| SSID | ssj0011805 |
| Score | 2.4640157 |
| SecondaryResourceType | review_article |
| Snippet | Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an... BACKGROUNDMedical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 887 |
| SubjectTerms | Adult Antitubercular Agents - therapeutic use Combined Modality Therapy Female Humans Male Middle Aged Pneumonectomy - statistics & numerical data Treatment Outcome Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Tuberculosis, Multidrug-Resistant - surgery Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - epidemiology Tuberculosis, Pulmonary - surgery |
| Title | Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26757804 https://www.proquest.com/docview/1772834747 |
| Volume | 62 |
| WOSCitedRecordID | wos000374248700011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFA5qRby4L3UjgtfQTifpZLxIUYuCLUWr9DZklYrM1M6M_n1fZrEnQfCSQ2DCkLz38uUt30PoggNEkNqjhGvRJlTJDglVKGBgLBBcK1G4Bl4eguGQTybhqHK4pVVaZW0TC0OtE-V85C0PYCD3KaDfq9kHcV2jXHS1aqGxjBo-QBkn1cFkEUXweJvVlKSh31JwvGr6VbpQfoGTxbXS3_zvD22hjQpQ4l4pAdtoycQ7aG1Qhcx30eypLHzGIsUixj39BjeZs3F4XOeYYwCuuKjE1fP8lTya1IFKmB_n0sxV_p7AxCXuxfj-p3wLj0pCVnwjMoEHJhOiojfZQ8_92_H1HanaLBAFCpkReIFZQ7UnPAbKzLra0oB5knFlOLdceZZy7TPH6SBD47elJ1RgqbXaBQGF7OyjlTiJzSHCcAZWwpsXQKKlhinJYA0ljC4YSIVtovN6LyMQYxebELFJ8jRa7GYTHZQHEs1Kvo2o03Wk-2169Ievj9E6QJpumVtzghoWlNicolX1mU3T-VkhHzAOR4NvFobKUQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surgery+as+an+Adjunctive+Treatment+for+Multidrug-Resistant+Tuberculosis%3A+An+Individual+Patient+Data+Metaanalysis&rft.jtitle=Clinical+infectious+diseases&rft.au=Fox%2C+Gregory+J&rft.au=Mitnick%2C+Carole+D&rft.au=Benedetti%2C+Andrea&rft.au=Chan%2C+Edward+D&rft.date=2016-04-01&rft.eissn=1537-6591&rft.volume=62&rft.issue=7&rft.spage=887&rft.epage=895&rft_id=info:doi/10.1093%2Fcid%2Fciw002&rft.externalDBID=NO_FULL_TEXT |